Somatic mutation of CDKN1B in small intestine neuroendocrine tumorsJoshua M. Francis, Matthew Meyerson, Adam Kieżun et al.|Nature Genetics|2013Cited by 374
Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapyMegan M. Tu, Dan Theodorescu, Garrett M. Dancik et al.|Communications Biology|2020Cited by 170
Targeting DDR2 enhances tumor response to anti–PD-1 immunotherapyMegan M. Tu, Dan Theodorescu, Francis Y. F. Lee et al.|Science Advances|2019Cited by 126
NPEPPS is a novel and druggable driver of platinum resistanceRobert T. Jones, James C. Costello|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 1